Photocure ASA

Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference

OSLO, Norway, April 5, 2024 - Photocure ASA (OSE: PHO), The Bladder Cancer

Company, announces that President and Chief Executive Officer, Dan Schneider

will present a corporate overview and host 1-on-1 meetings with investors at the

23[rd] Annual Needham Healthcare Conference being held virtually April 8-11,

Presentation Details:

Date: April 11, 2024

Time: 10:15am ET (4:15pm CET)

Webcast Link: https://wsw.com/webcast/needham117/pho.ol/2531984

About the Needham Healthcare Conference

The 23[rd] Annual Needham Virtual Healthcare Conference will feature leading

public and private companies in the Biotechnology, Specialty Pharmaceuticals,

Medical Technology, and Diagnostics sectors.

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, making

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us

at www.photocure.com, www.hexvix.com, www.cysview.com

For further information, please contact:

Dan Schneider

President and CEO

Photocure ASA

Erik Dahl

CFO

Photocure ASA

Tel: +4745055000

David Moskowitz

Vice President, Investor Relations

Photocure ASA

Tel: +1 202 280 0888

Media and IR enquiries:

Geir Bjørlo

Corporate Communications (Norway)

Tel: +47 91540000

AI Terminal